Robert W. Patterson: Before the Committee on Oversight and Government Reform U.S. House of Representatives, for a Hearing Entitled Use of Confidential Informants at ATF and DEA

Chuck Rosenberg: Before the Subcommittee on Crime, Terrorism, Homeland Security and Investigations Committee on the Judiciary U.S. House of Representatives, for a Hearing on Oversight of the Drug Enforcement Administration

As of October 2017, Drug Enforcement Administration (DEA) South Carolina-related National Forensic Laboratory Information System (NFLIS) data show that marijuana submissions indicate it is the second-most submitted illegal substance by incident by South Carolina law enforcement officials 2015. With preliminary reporting from 2016-17, the ranking of marijuana has slightly decreased.

Louis J. Milione: Before the Subcommittee on Oversight and Investigations Committee on Energy and Commerce United States House of Representatives

Analysis of “Marijuana Edibles” – Food Products Containing Marijuana or Marijuana Extracts – An Overview, Review, and Literature Survey. Microgram Journal 2017;14(1-4):9-32.

Analysis of Drug Trafficking Ledgers. (Microgram Journal 2017; 14(1-4):1-8)

This publication provides an overview of the prevalence of marijuana use among youth and young adults; the physical, academic, and social consequences; tips for how to get involved to prevent marijuana use among youth and young adults; and federal resources to assist in such efforts.

Robert W. Patterson: Before the Committee on Oversight and Government Reform, U.S. House of Representatives, for a Hearing Entitled Oversight of DEA’s Confidential Source Program

The 2016 National Drug Threat Assessment is a comprehensive strategic assessment of the threat posed to the United States by the trafficking and abuse of illicit and prescription drugs. This report combines federal, state, and local law enforcement reporting; public health data; news reports; and intelligence from other government agencies...

Louis J. Milione: Before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law Committee on the Judiciary, U.S. House of Representatives, for a Hearing on Treating the Opioid Epidemic: The State of Competition in the Markets for Addiction Medicine